To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
CL-218,872
CL-218,872 is a sedative and hypnotic drug used in scientific research.[1][2] It has similar effects to sedative-hypnotic benzodiazepine drugs such as triazolam, but is structurally distinct and so is classed as a nonbenzodiazepine hypnotic. Additional recommended knowledgeCL-218,872 is a GABAA partial agonist which is selective for the α1 subtype.[3][4][5] It has a range of effects including sedative, hypnotic, anxiolytic, anticonvulsant and amnestic actions, however the most prominent actions are sedation and amnesia, and CL-218,872 produces effects very similar to those of the hypnotic imidazopyridine derivative zolpidem in animal studies.[6][7][8] References
|
||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "CL-218,872". A list of authors is available in Wikipedia. |
- Isotopes_of_carbon
- Haplogroup_CF_(Y-DNA)
- Challenges in the development of electrocatalysts - What would have to change in research to develop efficient, stable and selective catalysts for industrial application?
- Glycylcycline
- AkzoNobel is stirring things up again with second global startup challenge - Paint the Future’s second global startup challenge launches